Company intelligence / Profile preview
Cascade Pharmaceuticals
Shanghai, Shanghai Municipality, Chinacascadepharm.com ↗
- Ownership
- Private
- Development stage
- Clinical
01
Overview
Cascade Pharmaceuticals is a clinical-stage biopharma company focused on innovative small molecule and peptide drugs for metabolic and inflammatory diseases. Its lead program, Linafexor, is a first-in-class FXR agonist in late-stage trials for liver-related indications. The pipeline includes multiple differentiated candidates targeting over ten distinct molecular targets with several programs advancing through early to mid-clinical development.
- Therapeutic areas
- Metabolic DisordersImmunologyGastroenterology
- Modalities
- Small moleculesPeptides
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on Cascade Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cascade Pharmaceuticals.